Table 2. Associations between miR-203 and clinicopathological characteristics.
Parameters | median (interquartile range) | P-value a |
---|---|---|
Age | 0.345 | |
<62 | 0.574(0.353–0.846) | |
≥62(median) | 0.521(0.242–0.811) | |
Gender | 0.088 | |
Male | 0.581(0.345–0.850) | |
Female | 0.443(0.248–0.686) | |
Grade | 0.565 | |
G2 | 0.628(0.370–0.781) | |
G3 | 0.511(0.331–0.832) | |
T stage | 0.305 | |
pT2 | 0.697(0.224–0.819) | |
pT3 | 0.531(0.356–0.859) | |
pT4 | 0.454(0.294–0.673) | |
Nodal status | 0.068 | |
Negative | 0.566(0.209–0.756) | |
Positive | 0.523(0.382–0.881) | |
Chemotherapy regimens | 0.803 | |
MVAC | 0.515(0.339–0.826) | |
GC | 0.637(0.281–0.830) | |
Progression | <0.001 | |
No | 0.727(0.490–0.894) | |
Yes | 0.309(0.129–0.556) |
a P-value was estimated by Mann-Whitney U test or Kruskal-Wallis test.